Asthma's Unlikely Ally: Semaglutide's Surprising Benefits The European Respiratory Society Congress in Barcelona, Spain, recently concluded, leaving behind a trail of research that challenges conventional wisdom on asthma and chronic obstructive pulmonary disease (COPD).
At the forefront of this discussion is semaglutide, an active ingredient found in both Ozempic and Wegovy.
New evidence suggests that semaglutide may offer a surprising benefit to people living with asthma: a nearly 40% reduction in asthma attacks.